# FOXP3

## Overview
FOXP3 is a gene that encodes the forkhead box P3 protein, a transcription factor that plays a pivotal role in the immune system, particularly in the development and function of regulatory T cells (Tregs). The FOXP3 protein is categorized as a transcription factor due to its ability to bind DNA and regulate gene expression. It is essential for maintaining immune homeostasis and preventing autoimmune diseases by promoting the development of Tregs, which are crucial for immunological self-tolerance and the suppression of excessive immune responses (Yagi2004Crucial; Li2007FOXP3). Mutations in the FOXP3 gene can lead to severe autoimmune disorders, such as Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) syndrome, underscoring its critical role in immune regulation (Georgiev2019Regulatory). The protein's function is modulated through various interactions and post-translational modifications, which are vital for its regulatory activities in Tregs (Deng2019Foxp3).

## Structure
The FOXP3 protein is a transcription factor with a complex molecular structure essential for its function in regulatory T cells. It is composed of several distinct domains: a proline-rich N-terminal domain, a central zinc finger domain, a leucine zipper domain, and a highly conserved C-terminal forkhead domain (Grover2021FOXP3; Zeng2011Domain). The proline-rich N-terminal domain is unique to FOXP3 and plays a crucial role in transcriptional repression and Treg development (Grover2021FOXP3). The zinc finger and leucine zipper domains are critical for DNA binding and oligomerization, allowing FOXP3 to form homo- and hetero-oligomers, including dimers and tetramers (Li2007FOXP3; Zeng2011Domain). The forkhead domain is responsible for DNA binding and nuclear localization (Grover2021FOXP3).

FOXP3 undergoes various post-translational modifications, including phosphorylation and acetylation, which influence its stability and function. Acetylation at specific lysine residues affects dimerization and suppressive activity (Deng2019Foxp3). Phosphorylation sites such as Ser-418 and Tyr-342 modulate its activity and interactions, impacting Treg function (Deng2019Foxp3). These structural features and modifications are crucial for FOXP3's role in regulating immune responses.

## Function
The FOXP3 gene encodes a transcription factor that is crucial for the development and function of regulatory T cells (Tregs), specifically the CD25+CD4+ subset, in humans. These Tregs play a vital role in maintaining immunological self-tolerance and regulating immune responses. FOXP3 is preferentially expressed in peripheral CD25+CD4+ T cells, particularly in the CD25+CD45RO+ subset, and is not induced in naive T cells upon TCR stimulation. However, retroviral gene transfer of FOXP3 can convert naive T cells into a regulatory phenotype similar to natural Tregs, which exhibit impaired proliferation and cytokine production upon TCR stimulation and can suppress the proliferation of other T cells in a contact-dependent manner (Yagi2004Crucial).

FOXP3 acts as a master regulatory gene for Treg development and function, and its expression is a reliable marker for identifying Tregs in humans. The gene is crucial for the up-regulation of Treg-associated molecules such as CD25, CD45RO, GITR, and CTLA-4, which are essential for the suppressive activity of Tregs (Yagi2004Crucial). Mutations in FOXP3 can lead to immune dysregulation syndromes like IPEX, highlighting its importance in preventing autoimmune diseases (Yagi2004Crucial).

## Clinical Significance
Mutations in the FOXP3 gene are primarily associated with Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) syndrome, a severe autoimmune disorder. IPEX syndrome is characterized by symptoms such as autoimmune enteropathy, type 1 diabetes, eczematous dermatitis, and immune-mediated cytopenias. These manifestations result from unrestrained T cell activation and autoantibody production due to FOXP3 mutations, particularly those affecting the forkhead (FKH) DNA-binding domain (Bacchetta2016From; Georgiev2019Regulatory). 

FOXP3 mutations can also lead to a deficiency in regulatory T cells (Tregs), causing a range of autoimmune and allergic conditions. The gene's dysfunction is linked to conditions like autoimmune thyroid diseases, type 1 diabetes, and systemic lupus erythematosus (ODA2013Genetic). 

Alterations in FOXP3 expression levels are implicated in cancer, where high levels of Tregs are observed, suggesting a complex role in disease progression (ODA2013Genetic). The gene's interactions with various transcription factors and cofactors, such as TIP60 and RUNX1, are crucial for its function, and disruptions in these interactions can lead to immune dysregulation (Grover2021FOXP3; Torgerson2007Immune).

## Interactions
FOXP3 interacts with a variety of proteins and nucleic acids, forming complexes that are crucial for its function in regulatory T cells. It physically associates with the nuclear factor of activated T cells (NFAT) and NF-κB, acting as a transcriptional corepressor. This interaction is demonstrated by coimmunoprecipitation techniques, showing that FOXP3 binds to the P65 subunit of NF-κB and NFAT, but not to control proteins like RSK2 (Bettelli2005Foxp3). The FOXP3 protein also forms a cooperative complex with NFAT and DNA, replacing the NFAT:AP-1:DNA complex at certain sites, such as those in the Il2 promoter. This interaction is crucial for modulating gene expression in regulatory T cells (Wu2006FOXP3).

FOXP3's interaction with NFAT is further supported by structural studies, which reveal that mutations disrupting the NFAT:FOXP3 interface impair FOXP3's function without affecting its DNA binding ability (Wu2006FOXP3). Additionally, FOXP3 forms complexes with histone acetyltransferase TIP60 and class II histone deacetylases HDAC7 and HDAC9, which are essential for its transcriptional repression activity (Li2007FOXP3). These interactions highlight the multifaceted role of FOXP3 in regulating gene expression through both direct DNA binding and complex formation with other proteins.


## References


[1. (Wu2006FOXP3) Yongqing Wu, Madhuri Borde, Vigo Heissmeyer, Markus Feuerer, Ariya D. Lapan, James C. Stroud, Darren L. Bates, Liang Guo, Aidong Han, Steven F. Ziegler, Diane Mathis, Christophe Benoist, Lin Chen, and Anjana Rao. Foxp3 controls regulatory t cell function through cooperation with nfat. Cell, 126(2):375–387, July 2006. URL: http://dx.doi.org/10.1016/j.cell.2006.05.042, doi:10.1016/j.cell.2006.05.042. This article has 918 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2006.05.042)

[2. (Deng2019Foxp3) Guoping Deng, Xiaomin Song, Shigeyoshi Fujimoto, Ciriaco A. Piccirillo, Yasuhiro Nagai, and Mark I. Greene. Foxp3 post-translational modifications and treg suppressive activity. Frontiers in Immunology, October 2019. URL: http://dx.doi.org/10.3389/fimmu.2019.02486, doi:10.3389/fimmu.2019.02486. This article has 127 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2019.02486)

[3. (Zeng2011Domain) Wei-ping Zeng, Vincent E. Sollars, and Andrea Del Pilar Belalcazar. Domain requirements for the diverse immune regulatory functions of foxp3. Molecular Immunology, 48(15–16):1932–1939, September 2011. URL: http://dx.doi.org/10.1016/j.molimm.2011.05.023, doi:10.1016/j.molimm.2011.05.023. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.molimm.2011.05.023)

[4. (Torgerson2007Immune) Troy R. Torgerson and Hans D. Ochs. Immune dysregulation, polyendocrinopathy, enteropathy, x-linked: forkhead box protein 3 mutations and lack of regulatory t cells. Journal of Allergy and Clinical Immunology, 120(4):744–750, October 2007. URL: http://dx.doi.org/10.1016/j.jaci.2007.08.044, doi:10.1016/j.jaci.2007.08.044. This article has 228 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.jaci.2007.08.044)

[5. (Yagi2004Crucial) Haruhiko Yagi, Takashi Nomura, Kyoko Nakamura, Sayuri Yamazaki, Toshio Kitawaki, Shohei Hori, Michiyuki Maeda, Masafumi Onodera, Takashi Uchiyama, Shingo Fujii, and Shimon Sakaguchi. Crucial role of foxp3 in the development and function of human cd25+cd4+ regulatory t cells. International Immunology, 16(11):1643–1656, October 2004. URL: http://dx.doi.org/10.1093/intimm/dxh165, doi:10.1093/intimm/dxh165. This article has 1124 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/intimm/dxh165)

[6. (Grover2021FOXP3) Payal Grover, Peeyush N. Goel, Ciriaco A. Piccirillo, and Mark I. Greene. Foxp3 and tip60 structural interactions relevant to ipex development lead to potential therapeutics to increase foxp3 dependent suppressor t cell functions. Frontiers in Pediatrics, February 2021. URL: http://dx.doi.org/10.3389/fped.2021.607292, doi:10.3389/fped.2021.607292. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fped.2021.607292)

[7. (Bettelli2005Foxp3) Estelle Bettelli, Maryam Dastrange, and Mohamed Oukka. Foxp3 interacts with nuclear factor of activated t cells and nf-κb to repress cytokine gene expression and effector functions of t helper cells. Proceedings of the National Academy of Sciences, 102(14):5138–5143, March 2005. URL: http://dx.doi.org/10.1073/pnas.0501675102, doi:10.1073/pnas.0501675102. This article has 417 citations.](https://doi.org/10.1073/pnas.0501675102)

[8. (ODA2013Genetic) JULIE MASSAYO MAEDA ODA, BRUNA KARINA BANIN HIRATA, ROBERTA LOSI GUEMBAROVSKI, and MARIA ANGELICA EHARA WATANABE. Genetic polymorphism in foxp3 gene: imbalance in regulatory t-cell role and development of human diseases. Journal of Genetics, 92(1):163–171, April 2013. URL: http://dx.doi.org/10.1007/s12041-013-0213-7, doi:10.1007/s12041-013-0213-7. This article has 84 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12041-013-0213-7)

[9. (Georgiev2019Regulatory) Peter Georgiev, Louis-Marie Charbonnier, and Talal A. Chatila. Regulatory t cells: the many faces of foxp3. Journal of Clinical Immunology, 39(7):623–640, September 2019. URL: http://dx.doi.org/10.1007/s10875-019-00684-7, doi:10.1007/s10875-019-00684-7. This article has 205 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s10875-019-00684-7)

[10. (Li2007FOXP3) Bin Li, Arabinda Samanta, Xiaomin Song, Kathryn T. Iacono, Kathryn Bembas, Ran Tao, Samik Basu, James L. Riley, Wayne W. Hancock, Yuan Shen, Sandra J. Saouaf, and Mark I. Greene. Foxp3 interactions with histone acetyltransferase and class ii histone deacetylases are required for repression. Proceedings of the National Academy of Sciences, 104(11):4571–4576, March 2007. URL: http://dx.doi.org/10.1073/pnas.0700298104, doi:10.1073/pnas.0700298104. This article has 331 citations.](https://doi.org/10.1073/pnas.0700298104)

[11. (Bacchetta2016From) Rosa Bacchetta, Federica Barzaghi, and Maria‐Grazia Roncarolo. From ipex syndrome to foxp3 mutation: a lesson on immune dysregulation. Annals of the New York Academy of Sciences, 1417(1):5–22, February 2016. URL: http://dx.doi.org/10.1111/nyas.13011, doi:10.1111/nyas.13011. This article has 245 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/nyas.13011)